Pockit Diagnostics, founded in 2017, has developed a family of patents protecting novel blood biomarkers for stroke detection. These biomarkers enable faster and more accurate stroke diagnosis, reducing disabilities and deaths after a stroke. The company's biomarkers can be used for Large Vessel Occlusion (LVO) stroke sub-type identification on the spot, allowing for improved care to patients in a cost-effective way. Pockit's mission is to bring excellence to medical diagnosis, providing products that help clinicians, paramedics, and nurses deliver better care to patients.